RLAY vs ZBH · rev $3.4M vs P/E 23, rev $4.26B
Relay Therapeutics Inc (RLAY) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
RLAY currently screens at market cap $3.39B. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the RLAY and ZBH stock pages for the full models.
Not investment advice.